Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
BRAI enters the new week with a peculiar disconnect: short sellers are quietly covering, yet borrowing the stock remains eye-wateringly expensive, a combination that makes the lending market worth watching closely.
The short side of BRAI tells a story of steady retreat. Short interest has fallen nearly 50% over the past month, dropping to around 71,400 shares. The weekly decline is even sharper, down roughly 23% in five sessions. The direction is unambiguous: bears are pulling back. Yet borrow costs have barely moved in response. The cost to borrow sits at 711%, down only 9% on the week and 11% on the month despite that large reduction in shares short. At that rate, holding a short position costs more than seven times the stock's value per year. That the rate has barely budged even as shorts exit suggests the lending pool for BRAI is thin and structural, not reactive to demand fluctuations. Availability has tightened meaningfully too, dropping 41% in a week to a reading of 71%, meaning roughly one share is available for every 1.4 already lent out. That is well off the 52-week tightest level of 9.5%, but the direction of travel this week is toward a tighter pool, not a looser one.
The ownership picture underscores why the borrow market behaves this way. The two largest shareholders, Natraj Balasubramanian and Chetan Saligrama, together hold roughly 66% of total shares. With that much of the register locked up in concentrated insider hands, the actual float available to lend is thin by design. Smaller institutional positions are minimal: FMR added 32,568 shares as of July, and Jane Street and Geode Capital each built small new positions around 43,000 shares in the June quarter. Those flows are too small to move the dial, but they confirm that a handful of institutional names have been quietly establishing footholds.
The ORTEX short score has ticked up to 59.3 from 56.4 two weeks ago, a moderate reading that reflects the high borrow cost and tightening availability more than any aggressive build in short positions. The score is not at an extreme, but the direction of the composite is upward even as the raw share count falls, a sign that the cost and availability components are doing more work in the index than the volume of short interest itself. A previous ORTEX note flagged that the stock's fundamental score has deteriorated, with the f-score weakening and valuation multiples looking stretched relative to earnings power. Enterprise value is listed at roughly $615 million, though with no analyst coverage or consensus price target in the data, there is no Street framework against which to test that figure.
Price action adds another layer of tension. BRAI closed at $4.71 on Tuesday, up 3.7% on the day but down 14% on the week and 16% over the past month. Nasdaq peer DUOT gained about 3% on the week while HOLO fell 8%, suggesting BRAI's slide is not entirely a sector-wide move. With earnings scheduled for 10 November, the next meaningful fundamental datapoint is five weeks out. Between now and then, the question is whether availability continues to tighten toward last year's low of 9.5%, and whether the cost to borrow finally starts to respond to the ongoing reduction in shares short.
See the live data behind this article on ORTEX.
Open BRAI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
